. | . |
Alcoholism drug may help design HIV cure: study by Staff Writers Paris (AFP) Nov 16, 2015
A treatment for alcoholism can reactivate dormant HIV, potentially allowing other drugs to spot and kill the virus hiding out in human immune cells, researchers said Tuesday. The medication, called Disulfiram, draws out the AIDS-causing virus without any side effects for patients, according to a study published in The Lancet. In people undergoing treatment for AIDS, the virus can take cover in certain cells and hide away, only to reemerge once therapy is stopped. This latency has been one of the biggest hurdles in developing a cure. "Waking up" the virus - and then destroying it -- is a promising strategy for ridding patients of HIV. But other drugs which are able to rouse HIV from its dormant state are toxic to humans. In clinical trials led by Sharon Lewin, a professor at the University of Melbourne, 30 people on antiretroviral treatment (ART) were given increasing doses of Disulfiram over a period of three days. At the highest dose, there was evidence of slumbering HIV being stimulated, with no side effects. "This trial clearly demonstrates that Disulfiram is not toxic and is safe to use, and could quite possibly be the game changer we need," Lewin said in a statement. The next step will be to test Disulfiram's rousing effect in combination with a virus-killing drug. "Waking up the virus is only the first step to eliminating it," said the study's lead author Julian Elliott, head of clinical research in the department of infectious diseases at Alfred Hospital in Melbourne, Australia. "Now we need to work out how to get rid of the infected cell." Approximately 34 million people have died of HIV-related causes worldwide. By the end of 2014, there were an estimated 36.9 people living with HIV globally.
Related Links Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |